Item Posts Archive - Page 46 of 1770 - Medivizor
Navigation Menu

Evaluating the long-term effectiveness and safety of 3-month versus 6-month modified FOLFOX/CAPOX treatment after surgery in patients with stage 3 colon cancer.

Evaluating the long-term effectiveness and safety of 3-month versus 6-month modified FOLFOX/CAPOX treatment after surgery in patients with stage 3 colon cancer.

Posted by on Oct 13, 2022 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the long-term effectiveness and safety of 3-month versus 6-month modified FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin) or CAPOX (capecitabine and oxaliplatin) treatment after surgery in patients with stage 3 colon cancer. The data showed that 3-month modified FOLFOX/CAPOX treatment was as effective and safe as...

Read More

Evaluating the effectiveness and safety of low-intensity extracorporeal shock wave therapy for patients with diabetes and erectile dysfunction.

Evaluating the effectiveness and safety of low-intensity extracorporeal shock wave therapy for patients with diabetes and erectile dysfunction.

Posted by on Oct 7, 2022 in Erectile dysfunction | 0 comments

In a nutshell This study evaluated the effectiveness and safety of low-intensity extracorporeal shock wave therapy (Li-ESWT) for patients with diabetes and erectile dysfunction (ED). The data showed that Li-ESWT was safe and effective in improving the symptoms of ED in these patients. Some background Erectile dysfunction (ED) consists of the inability...

Read More

Evaluating the effectiveness and safety of low-intensity extracorporeal shock wave therapy for patients with diabetes and erectile dysfunction.

Evaluating the effectiveness and safety of low-intensity extracorporeal shock wave therapy for patients with diabetes and erectile dysfunction.

Posted by on Oct 7, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effectiveness and safety of low-intensity extracorporeal shock wave therapy (Li-ESWT) for patients with diabetes and erectile dysfunction (ED). The data showed that Li-ESWT was safe and effective in improving the symptoms of ED in these patients. Some background Erectile dysfunction (ED) consists of the inability...

Read More

Comparing the effectiveness of microdissection testicular sperm extraction versus multiple needle-pass percutaneous testicular sperm aspiration in infertile men with non-obstructive azoospermia.

Comparing the effectiveness of microdissection testicular sperm extraction versus multiple needle-pass percutaneous testicular sperm aspiration in infertile men with non-obstructive azoospermia.

Posted by on Oct 7, 2022 in Infertility | 0 comments

In a nutshell This study directly compared the effectiveness of microdissection testicular sperm extraction (mTESE) versus multiple needle-pass percutaneous testicular sperm aspiration (TESA) in infertile men with non-obstructive azoospermia (NOA). The data showed that the sperm retrieval rate was higher with mTESE than with multiple needle-pass...

Read More

Evaluating the effectiveness and safety of elacestrant versus standard hormonal therapy in patients with ER+/HER2- advanced BC.

Evaluating the effectiveness and safety of elacestrant versus standard hormonal therapy in patients with ER+/HER2- advanced BC.

Posted by on Oct 7, 2022 in Breast cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of elacestrant (RAD1901) versus standard hormonal therapy in patients with estrogen receptor-positive (ER+) and HER2-negative (HER2-) advanced breast cancer (BC). The data showed that elacestrant significantly improved survival without cancer worsening with manageable side effects in these...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor